Johnson and Johnson 2012 Annual Report Download - page 4

• The addition of Synthes, Inc. to our family of companies marked the largest acquisition in our history and, combined
with DePuy, creates the world’s largest, most comprehensive orthopaedics and neurologics business, the DePuy Synthes
Companies. We will continue the exciting integration of Synthes into our Medical Devices and Diagnostics business
segment in the coming year.
• In our Consumer business segment, we will continue restoring a reliable supply of our McNeil over-the-counter
medicines. The work to bring our plants fully online is progressing. We expect to return a consistent supply of key
products to the market over the course of 2013. We are definitely making good progress; however, we must move from
good to great this year.
More details on the progress of our three business segments can be found in the Business Segment Highlights section of this
Annual Report.
ENSURING ROBUST GROWTH
Within the context of Our Credo and strategic framework there are specific areas of focus for Johnson & Johnson—our Growth
Drivers—that will help ensure robust growth for the future.
• First is our commitment to innovation to create value; not just innovation in products and services, but in everything we
do and everywhere we operate. We need a constant flow of new ideas and different approaches to meet the challenges and
opportunities of the future.
• Second, our global reach must be brought to life with a local focus. That puts critical decision-making where the needs are
and where our global resources live. We believe our commitment to decentralized management provides a competitive
advantage in all of our businesses and all of our markets.
• Third, we will have a laser focus on excellence in execution. Across our enterprise, we have built greater accountability for
quality into the requirements for all of our leaders. This has strengthened quality and compliance at the enterprise level by
taking specific steps to reduce variation and increase governance. We’ve redefined standards and processes in our supply
chain to, most importantly, improve the level of execution, and to deliver efficiencies that can free resources for
investment.
• Fourth, we will continue to foster a purpose-driven organization and develop leadership at every level of our Company.
This is essential for us to deliver on the responsibilities that come along with our global leadership.
ADDRESSING A GLOBAL CHALLENGE
Our broad base in health care gives us a unique perspective on the needs, fears, frustrations and hopes of consumers, patients, their
families and health professionals worldwide. I believe that a healthier world is not just a happier world, but also one that has much
greater economic stability and provides a foundation for individual and societal advancement. I’m very proud of the progress we
have made toward our purpose of caring for the world, one person at a time. But all of us are keenly aware of the gaps that still exist
in the world.
For example, there is a gap in access to basic health care. Whether because of a lack of trained professionals, inadequate
infrastructure or cultural obstacles, addressing this gap is a key long-term goal for us as the leader in global health care.
There is a gap in adequate mental health care services. This has come to public attention in glaring examples of recent tragedies in
the United States. Again, this gap may be a result of a lack of trained professionals or the stigma that too often prevents people from
seeking help.
There is a gap in preventive medicine that often focuses societies on “sick care” rather than health care. This is a particular focus
for me, and for all of us at Johnson & Johnson, not only because of the depth of the problem, but also because of the scope of the
opportunity.
Can we close these gaps? We are committed to convening a dialogue that recognizes and addresses these significant gaps in
caring. We will work with communities and local partners around the world to take meaningful action to improve people’s lives.
That’s a global challenge we aim to address. Working together we can… and we must.
OUR INSPIRATION
The challenges we face in this ever-changing health care landscape will require time, vigilance and dedication to solve. All of us here
at Johnson & Johnson realize we are on a journey. Every day, though, I am inspired by yet another story of how we have delivered on
Our Credo.
JOHNSON & JOHNSON 2012 ANNUAL REPORT